Mamoru Kiniwa Selected Research

Messenger RNA (mRNA)

7/2011	Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
5/2011	In vivo evidence for a significant role of folylpolyglutamate synthase in combined chemotherapy with oral fluoropyrimidine, UFT or S-1, and leucovorin.
10/2009	Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mamoru Kiniwa Research Topics

Disease

7	Neoplasms (Cancer) 12/2017 - 05/2009
6	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 05/2009
5	Inflammation (Inflammations) 12/2015 - 04/2003
3	Breast Neoplasms (Breast Cancer) 05/2012 - 01/2010
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2011 - 02/2009
2	Overactive Urinary Bladder (Overactive Bladder) 04/2013 - 09/2012
2	Colonic Neoplasms (Colon Cancer) 11/2010 - 05/2009
2	Hyperplasia 10/2009 - 02/2009
2	Body Weight (Weight, Body) 05/2009 - 06/2002
2	Infections 05/2004 - 03/2004
2	Rheumatoid Arthritis 04/2003 - 02/2002
1	Body Weight Changes 05/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2012
1	Esophagitis 01/2012
1	Peptic Esophagitis (Reflux Esophagitis) 01/2012
1	Urinary Retention 10/2011
1	Stomach Neoplasms (Stomach Cancer) 05/2010
1	Asthma (Bronchial Asthma) 01/2010
1	Vomiting 01/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2010
1	Eosinophilia 01/2010
1	Lower Urinary Tract Symptoms 10/2009
1	Cystitis 10/2007
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 10/2007
1	Hypersensitivity (Allergy) 05/2006
1	Allergic Rhinitis 05/2006

Drug/Important Bio-Agent (IBA)

6	Fluorouracil (Carac)FDA LinkGeneric 05/2012 - 05/2009
3	Proteins (Proteins, Gene)FDA Link 04/2015 - 05/2011
3	Messenger RNA (mRNA)IBA 07/2011 - 10/2009
3	Folic Acid (Vitamin M)FDA LinkGeneric 05/2011 - 05/2009
3	Leucovorin (Folinic Acid)FDA Link 05/2011 - 05/2009
2	trifluridine tipiracil drug combinationIBA 12/2017 - 04/2015
2	lafutidineIBA 01/2012 - 05/2004
2	Estrogens (Estrogen)FDA Link 07/2011 - 01/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2011 - 01/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2011 - 01/2010
2	Estrogen ReceptorsIBA 07/2011 - 01/2010
2	ProdrugsIBA 11/2010 - 04/2003
2	AntigensIBA 01/2010 - 06/2002
2	Interleukin-8 (Interleukin 8)IBA 05/2004 - 03/2004
2	4- (3,4,5- trimethoxyphenyl)- 6- (2,4,5- trimethoxyphenyl)- 2- diethylaminopyrimidineIBA 04/2003 - 02/2002
1	Trifluridine (Viroptic)FDA LinkGeneric 12/2017
1	ParaffinIBA 01/2016
1	Peroxidase (Myeloperoxidase)IBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 12/2015
1	nitroxylIBA 12/2015
1	Cholinergic Antagonists (Anticholinergics)IBA 04/2013
1	propiverineIBA 09/2012
1	Bevacizumab (Avastin)FDA Link 05/2012
1	AntibodiesIBA 05/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012
1	Tyrosine Kinase InhibitorsIBA 05/2012
1	Sunitinib (Sutent)FDA Link 05/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2012
1	Sorafenib (BAY 43-9006)FDA Link 05/2012
1	Cetuximab (Erbitux)FDA Link 05/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2012
1	Histamine H2 AntagonistsIBA 01/2012
1	Famotidine (Pepcid)FDA LinkGeneric 01/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2011
1	Tamsulosin (Flomax)FDA LinkGeneric 10/2011
1	Anastrozole (Arimidex)FDA LinkGeneric 07/2011
1	Aromatase InhibitorsIBA 07/2011
1	Aromatase (CYP19)IBA 07/2011
1	Complementary DNA (cDNA)IBA 07/2011
1	Small Interfering RNA (siRNA)IBA 05/2011
1	folylpolyglutamate synthetaseIBA 05/2011
1	Thymidylate SynthaseIBA 11/2010
1	TegafurIBA 11/2010
1	UracilIBA 11/2010
1	Lapatinib (GW572016)FDA Link 05/2010
1	human ERBB2 proteinIBA 05/2010
1	Trastuzumab (Herceptin)FDA Link 05/2010
1	Cytotoxins (Cytolysins)IBA 05/2010
1	EmeticsIBA 01/2010
1	Phosphodiesterase 4 InhibitorsIBA 01/2010
1	LipopolysaccharidesIBA 01/2010
1	Platelet Activating FactorIBA 01/2010
1	TAS-203IBA 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	CilomilastIBA 01/2010
1	benzimidazoleIBA 01/2010
1	Dihydrotachysterol (AT 10)IBA 01/2010
1	naftopidilIBA 10/2009
1	Chlormadinone Acetate (Chlormadinone)IBA 02/2009
1	Testosterone (Sustanon)FDA Link 02/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2009
1	Androgen Antagonists (Antiandrogens)IBA 02/2009
1	CytokinesIBA 10/2007
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 10/2007
1	suplatast tosilateIBA 10/2007
1	ProstaglandinsIBA 05/2006
1	Prostaglandin D2IBA 05/2006
1	Triglycerides (Triacylglycerol)IBA 12/2004

Therapy/Procedure

8	Therapeutics 05/2012 - 10/2007
1	Aftercare (After-Treatment) 07/2011
1	Drug Therapy (Chemotherapy) 05/2011
1	Oral Administration 01/2010
1	Intravesical Administration 10/2007